BOB (psychedelic)
BOB (psychedelic) is a psychedelic drug that belongs to the 2C family of substances, originally synthesized by Alexander Shulgin. It is chemically known as 4-bromo-2,5-dimethoxyphenethylamine.
History[edit]
BOB was first synthesized by Alexander Shulgin, a renowned chemist and psychopharmacologist, who documented his findings in the book PiHKAL. Shulgin's extensive work on the 2C family of drugs has contributed significantly to the understanding of these substances.
Chemistry[edit]
BOB is a phenethylamine, a broad class of compounds that also includes other psychedelic substances like mescaline and 2C-B. The chemical structure of BOB includes a phenethylamine core, with a bromine atom at the 4th position, and two methoxy groups at the 2nd and 5th positions of the phenyl ring.
Pharmacology[edit]
The exact mechanism of action of BOB is not fully understood. However, like other 2C drugs, it is believed to work primarily by binding to serotonin receptors in the brain, particularly the 5-HT2A receptor. This receptor is known to play a key role in the effects of many psychedelic substances.
Effects[edit]
The effects of BOB can vary greatly depending on the dose, the individual's physiology, and the context in which it's used. Users often report intense visual hallucinations, altered thought processes, and heightened emotions. As with all psychedelic substances, the potential for negative psychological reactions, such as anxiety and paranoia, is also present.
Legal Status[edit]
The legal status of BOB varies by country. In many places, it is classified as a controlled substance, making its manufacture, distribution, or use illegal.
See Also[edit]

This psychedelic-related article is a stub. You can help WikiMD by expanding it.
BOB (psychedelic)[edit]
-
4-bromo-2,5,beta-trimethoxy-phenethylamine
-
BOB 3D sticks
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
